You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
苑東生物(688513.SH):青木製藥擬投建高端化學原料藥及製劑生產基地項目
格隆匯 03-23 17:06

格隆匯3月23日丨苑東生物(688513.SH)公佈,公司全資子公司四川青木製藥有限公司(以下簡稱“青木製藥”)擬在四川省眉山市東坡區西部藥谷投資建設高端化學原料藥及製劑生產基地項目,項目佔地約240畝,項目投資總金額為4.8億元人民幣。

一期項目計劃於青木製藥在眉山市東坡區人民政府交地、完成《國有建設用地使用權出讓合同》簽訂之日起12個月內進場施工,建設週期不超過24個月。初步計劃於2022年一季度開工,2024年一季度投產。

二期項目計劃於一期項目建成達產之日起12個月內啟動建設,建設週期不超過24個月。

項目投資強度不低於200萬元/畝;產出強度不低於300萬元/畝/年;項目全部達產後,税收貢獻不低於20萬元/畝/年。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account